PedAM
Pediatric Disease Annotations & Medicines
| Disease | multiple sclerosis |
| Symptom | |spasticity |
| Sentences | 58 |
| PubMedID- 21476822 | Retrospective observational study of the management of multiple sclerosis patients with resistant spasticity in spain: the '5e' study. |
| PubMedID- 22354705 | Activation of cannabinoid (cb) receptors decreases nociceptive transmission in acute, inflammatory and neuropathic pain states; however, although the use of cannabis derivatives has been recently accepted as a useful alternative for the treatment of spasticity and pain in patients with multiple sclerosis, the effects of cb receptor agonists in muscular pain have hardly been studied. |
| PubMedID- 24699310 | Sativex((r)) is an oromucosal spray used to treat spasticity in multiple sclerosis sufferers in some european countries, the united kingdom, canada and new zealand. |
| PubMedID- 26445705 | spasticity in multiple sclerosis and role of glatiramer acetate treatment. |
| PubMedID- 20505376 | F-wave characteristics as surrogate markers of spasticity in patients with secondary progressive multiple sclerosis. |
| PubMedID- 23011861 | Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids. |
| PubMedID- 25835097 | A breakthrough for the treatment of spasticity in multiple sclerosis. |
| PubMedID- 21982341 | It is used for the symptomatic relief of spasticity associated with multiple sclerosis or with spinal cord injury or disease. |
Page: 1 2